Kymera Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Atlas Venture Fund X, L.P.(6.4%),Atlas Venture Associates X, L.P.(6.4%)等
Kymera Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(10.3%)
Kymera Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Avoro Capital Advisors LLC(9.99%),Behzad Aghazadeh(9.99%)
Kymera Therapeutics | SC 13G:超过5%持股股东披露文件-FMR LLC(7.933%),Abigail P. Johnson(7.933%)
Kymera Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Wellington Management Group LLP(7.17%),Wellington Group Holdings LLP(7.17%)等
Kymera Therapeutics | 4:持股变动声明-董事 Esposito Pamela
Kymera Therapeutics | 4:持股变动声明-董事 Albers Jeffrey W.
Kymera Therapeutics | 4:持股变动声明-董事 BVF PARTNERS L P/IL
Kymera Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(9.3%),Baker Bros. Advisors (GP) LLC(9.3%)等
Kymera Therapeutics | 4:持股变动声明-董事 BAKER BROS. ADVISORS LP
Kymera Therapeutics | 4:持股变动声明-高管 Gollob Jared
Kymera Therapeutics | 4:持股变动声明-董事 Booth Bruce
Kymera Therapeutics | 4:持股变动声明-高管 Mainolfi Nello
Kymera Therapeutics | 4:持股变动声明-董事 BVF PARTNERS L P/IL
Kymera Therapeutics | 4:持股变动声明-高管 Jacobs Bruce N.
Kymera Therapeutics | 4:持股变动声明-董事 Sandor Victor
Kymera Therapeutics | 4:持股变动声明-董事 Booth Bruce
Kymera Therapeutics | 4:持股变动声明-董事 Esposito Pamela
Kymera Therapeutics | 4:持股变动声明-董事 Albers Jeffrey W.
Kymera Therapeutics | 4:持股变动声明-董事 Ridloff Elena
暂无数据
暂无数据